PharVision Advisers LLC Takes $317,000 Position in Enhabit, Inc. (NYSE:EHAB)

PharVision Advisers LLC purchased a new stake in Enhabit, Inc. (NYSE:EHAB - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 40,554 shares of the company's stock, valued at approximately $317,000. PharVision Advisers LLC owned about 0.08% of Enhabit at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Squarepoint Ops LLC bought a new stake in Enhabit in the fourth quarter valued at approximately $185,000. Two Sigma Advisers LP increased its holdings in shares of Enhabit by 40.1% during the 4th quarter. Two Sigma Advisers LP now owns 27,600 shares of the company's stock worth $216,000 after acquiring an additional 7,900 shares during the last quarter. State of Wyoming raised its stake in Enhabit by 95.7% in the 4th quarter. State of Wyoming now owns 71,307 shares of the company's stock valued at $557,000 after acquiring an additional 34,861 shares during the period. Systematic Financial Management LP lifted its holdings in Enhabit by 8.6% during the 4th quarter. Systematic Financial Management LP now owns 1,996,113 shares of the company's stock valued at $15,590,000 after purchasing an additional 157,914 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its holdings in Enhabit by 3.4% during the 4th quarter. Point72 Asset Management L.P. now owns 341,678 shares of the company's stock valued at $2,669,000 after purchasing an additional 11,278 shares during the last quarter.

Enhabit Stock Performance

Enhabit stock traded up $0.29 during trading hours on Tuesday, hitting $10.51. The company had a trading volume of 36,775 shares, compared to its average volume of 454,180. The firm has a 50-day moving average of $8.72 and a 200 day moving average of $8.33. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The firm has a market cap of $532.19 million, a PE ratio of -4.53 and a beta of 1.61. Enhabit, Inc. has a one year low of $6.85 and a one year high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.07 by $0.03. The company had revenue of $259.90 million for the quarter, compared to the consensus estimate of $266.11 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. On average, sell-side analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reiterated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.